CJEU: Non-EU national may benefit from a right of residence
In order to guarantee the effectiveness of the rights conferred by citizenship of the EU, the conditions for the grant of that derived right of residence ought not, in principle, to be stricter than those laid down by the free movement directive.
Mr Toufik Lounes, an Algerian national, entered the UK in 2010 on a six-month visitor visa and then overstayed illegally. Ms Perla Nerea García Ormazábal, a Spanish national, moved to the UK as a student in 1996 and began working full time in the UK in 2004. She became a naturalised British citizen in 2009.
In April 2014, Mr Lounes and Ms García Ormazábal married. Following their marriage, Mr Lounes applied to the Secretary of State for the Home Department for the issue of a residence card as a family member of an EEA (European Economic Area) national. On 14 May 2014, he was served with a notice, together with a decision to remove him from the UK, on the grounds that he had overstayed in that State in breach of immigration controls.
In addition, by letter of 22 May 2014, the Secretary of State for the Home Department informed Mr Lounes that his application for a residence card had been refused. The letter stated that, in accordance with UK law, Ms García Ormazábal was no longer regarded as an ‘EEA national’ because she had acquired British nationality. Consequently, she was no longer entitled to rely on the rights conferred by the directive on free movement1 and Mr Lounes could not therefore claim a residence card as a family member of an EEA national.
Latest News from
Sahel and Central Africa: €210 million in EU humanitarian aid12/05/2021 09:25:00
The EU is reaffirming its solidarity with vulnerable people in countries in the Sahel and Central Africa through a humanitarian budget of €210 million in 2021.
Security and defence: EU to move forward on common security and defence11/05/2021 15:25:00
The Council yesterday approved conclusions affirming its determination to move forward on implementing the EU's security and defence agenda, enabling the EU to take more responsibility for its own security.
Trade of dual-use items: new EU rules adopted11/05/2021 13:25:00
The EU has upgraded its legislation on the export controls applicable to sensitive dual-use goods and technologies such as cyber-surveillance tools.
Conference on the Future of Europe: make your voice heard10/05/2021 15:25:00
Conference on the Future of Europe: make your voice heard.
Porto Social Summit: all partners commit to 2030 social targets10/05/2021 13:25:00
Partners have signed up to the three 2030 headline targets set in the Commission's European Pillar of Social Rights Action Plan in a joint Porto Social Commitment.
Speech by Vice-President Jourová at Riga StratCom Dialogue 202110/05/2021 12:38:00
Speech given recently (06 May 2021) by Vice-President Jourová at Riga StratCom Dialogue 2021.
Remarks by Commissioner Stella Kyriakides at the press conference on the EU Strategy for the development and availability of therapeutics10/05/2021 09:25:00
Remarks given recently (06 May 2021) by Commissioner Stella Kyriakides at the press conference on the EU Strategy for the development and availability of therapeutics.
PESCO: Canada, Norway and the United States will be invited to participate in the project Military Mobility07/05/2021 15:25:00
Following the requests of Canada, Norway and the United States of America to participate in the PESCO project Military Mobility, the Council yesterday adopted positive decisions authorising the coordinator of this project – the Netherlands – to invite the three countries. Canada, Norway and the United States of America will be the first third states to be invited to participate in a PESCO project.
Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics07/05/2021 13:25:00
The European Commission yesterday complemented the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'.